Special Issue "Epidemiology, Vaccinology and Surveillance of COVID-19"
Deadline for manuscript submissions: 30 June 2024 | Viewed by 10880
Interests: epidemiology of infectious diseases; reproductive health; big data research and application in health
Interests: epidemiology of infectious diseases; prevention; control and management of infectious diseases; maternal and child health; big data research and application in health
Special Issues, Collections and Topics in MDPI journals
At present, COVID-19 is still a global pandemic, and SARS-CoV-2 is constantly evolving and mutating, producing variants with different transmissibility and virulence. The rapid spread of COVID-19 causes enormous impacts on social, economic, and healthcare systems in the world. Effective treatments to block the spread of COVID-19 have not been developed yet, so countries implement a series of nontreatment interventions, such as social distancing, isolation, face masks, and quarantine, to reduce its rapid transmission. Therefore, we would like to encourage the presentation to this Special Issue of the molecular characterization of different SARS-CoV-2 variants and the epidemiological characterization of the COVID-19 caused by them. Given that the COVID-19 vaccine can effectively reduce the infection rate and severity rate of COVID-19, topics concerning vaccine effectiveness, safety, willingness to vaccinate, and hesitancy of vaccinating against COVID-19 will also be welcome. Adding new information on these topics could provide a better understanding of the pathogenesis of COVID-19 and help design new surveillance and prevention strategies.
Prof. Dr. Min Liu
Dr. Jue Liu
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vaccine adverse event
- vaccine hesitancy